Patent Assignment
Reel/Frame 062486/0868
Assignment of Assignor's Interest
Recorded: 2023-01-25
Pages: 11
Assignor
CADENT THERAPEUTICS, INC.
Executed: 2022-12-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties
(5)
N-Alkylaryl-5-Oxyaryl-Octahydro-Cyclopenta[C]Pyrrole Negative Allosteric Modulators of NR2B
N-Alkylaryl-5-Oxyaryl-Octahydro-Cyclopenta[C]Pyrrole Negative Allosteric Modulators of NR2B
N-Alkylaryl-5-Oxyaryl-Octahydro-Cyclopenta[C]Pyrrole Negative Allosteric Modulators of NR2B
Application:
16/991,684 →
Publication:
US 2020/0369610
N-Alkylaryl-5-Oxyaryl-Octahydro-Cyclopenta[C]Pyrrole Negative Allosteric Modulators of NR2B
N-Alkylaryl-5-Oxyaryl- Octahydro-Cyclopenta[C]Pyrrole Negative Allosteric Modulators of NR2B
Application:
62/056,284 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 5, 2015
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.
To: MNEMOSYNE PHARMACEUTICALS, INC.
Reel/Frame 035098/0170 →
Change of Name
Jan 23, 2019
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 048116/0477 →
Assignment of Assignor's Interest
Jun 19, 2019
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 049521/0328 →
Assignment of Assignor's Interest
Jun 19, 2019
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 049521/0522 →
Change of Name
Jan 25, 2023
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 062511/0834 →
Assignment of Assignor's Interest
Nov 7, 2024
From: LERNER, DANIEL MAURICE; SINGH, RANJIT K.; ORBAN, ANDRE
To: A.O. INTERNATIONAL II, INC.
Reel/Frame 069313/0495 →